Você procurou por: postmarketinškim (Esloveno - Inglês)

neželeni učinki, o katerih so poročali med postmarketinškim spremljanjem
undesirable effects observed during post-marketing surveillance

izkušnje s postmarketinškim nadzorom pri bolnikih, ki imajo rak želodca
post-marketing surveillance experience in gastric cancer patients

pro neželeni učinki med postmarketinškim nadzorom in kliničnimi študijami iv. faze
ge the additional adverse reactions in table 2 have been reported from postmarketing surveillance or phase iv clinical trials: lon table 2 undesirable effects in postmarketing surveillance and phase iv clinical studies no

tabela 2 neželeni učinki med postmarketinškim nadzorom in kliničnimi študijami iv. faze
table 2 undesirable effects in postmarketing surveillance and phase iv clinical studies

med postmarketinškim obdobjem so poročali o naslednjih reakcijah (pogostost neznana):
during post-marketing experience the following reactions have been reported (frequency unknown): -immune system disorders:

naslednje neželene učinke so zabeležili med postmarketinškim spremljanjem po cepljenju s cepivom ambirix.
the following adverse reactions were reported during post-marketing surveillance following vaccination with ambirix.

drugi neželeni učinki, o katerih so poročali med postmarketinškim nadzorom, so našteti spodaj:
additional adverse reactions reported during post-marketing surveillance are listed below.

med postmarketinškim obdobjem so bili opisani primeri srčnega popuščanja med uporabo pioglitazona v kombinaciji z insulinom ali pri bolnikih z anamnezo srčnega popuščanja.
there have been post-marketing cases of cardiac failure reported when pioglitazone was used in combination with insulin or in patients with a history of cardiac failure.

med postmarketinškim obdobjem so poročali o redkih primerih motenega delovanja jetrnih celic (glejte poglavje 4.8).
there have been rare reports of hepatocellular dysfunction during post-marketing experience (see section 4.8).

poleg tega so vključeni medicinsko pomembni neželeni učinki, opisani med postmarketinškim obdobjem; njihova pogostnost je navedena kot "ni znano".
in addition, the frequency of medically important adverse reactions reported from post-marketing experience is included as not known.

primeri kongestivnega srčnega popuščanja so bili opisani tudi med postmarketinškim obdobjem (pogostnost neznana) (glejte poglavje 4.4).
cases of chf have also been reported in post-marketing experience (frequency not known) (see section 4.4).

med postmarketinškim obdobjem so poročali o odpovedi jeter (pogostnost ni znana). lje Če je kateri od teh neželenih učinkov moteč, hud ali med nadaljevanjem zdravljenja ne mine, povejte vo svojemu zdravniku.
during post-marketing experience, liver failure has been reported (frequency unknown).